Navigation Links
Maxygen to Present at the JPMorgan 26th Annual Healthcare Conference
Date:12/28/2007

REDWOOD CITY, Calif., Dec. 28 /PRNewswire-FirstCall/ -- Maxygen, Inc. (Nasdaq: MAXY), a biotechnology company focused on the development of improved protein drugs, today announced that it will present at the JPMorgan 26th Annual Healthcare Conference on Monday, January 7, 2008 at 9:00 a.m. Pacific Time. Russell Howard, Maxygen's chief executive officer, and Santosh Vetticaden, Maxygen's chief medical officer, will present. A live webcast of the presentation can be accessed on Maxygen's website at http://www.maxygen.com/webcasts. A replay of the presentation will be available until February 7, 2008.

About Maxygen

Maxygen is a biopharmaceutical company focused on developing improved versions of protein drugs. We look for opportunities where our proprietary protein modification technologies can address significant therapeutic needs. Our lead program, MAXY-G34, is designed to be an improved version of G-CSF for the treatment of neutropenia. MAXY-G34 is currently in Phase II clinical trials. Also in our pipeline is a novel Factor VIIa for the treatment of hemophilia. Maxygen's approach to drug discovery and development may allow us to leverage the established development and regulatory paths of approved drugs. We believe this advantage translates to a greater chance of successfully bringing important new drugs to market. http://www.maxygen.com


'/>"/>
SOURCE Maxygen, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Maxygen Announces Hold on MAXY-alpha Development Program
2. Maxygen Third Quarter 2007 Financial Results Conference Call Notice
3. Maxygen Announces Upcoming Webcasts at Investor Conferences
4. Maxygen Reports Third Quarter 2007 Financial Results
5. Maxygen Licenses Dengue Vaccine Technology to sanofi pasteur
6. Imagenetix Inc. to Present at Noble Small Cap Financial Conference on August 21, 2007
7. Avicena Group to Present at Noble Financial Conference
8. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
9. Strategic Diagnostics to Present at Two Upcoming Investor Conferences
10. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
11. CEL-SCI to Present at the Noble Financial Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2017)... ... September 18, 2017 , ... ... the move of the SPIE Digital Library ( http://www.spiedigitallibrary.org ) on 15 August ... create an improved user experience and incorporate a number of enhancements and new ...
(Date:9/17/2017)... (PRWEB) , ... September 17, 2017 , ... ... from the South Korean Ministry of Food and Drug Safety (KMFDS) for an ... GLS-5300, against the Middle East Respiratory Syndrome coronavirus (MERS-CoV). The study in Korea ...
(Date:9/14/2017)... UK (PRWEB) , ... September 14, 2017 , ... ... most innovative minds in pharma and biotech at the third annual DrugDev Summit, ... conference that brings together the world’s most progressive clinical research leaders for best ...
(Date:9/14/2017)... Australia (PRWEB) , ... September 14, 2017 , ... ... first viscoelastic Freedom Lumbar Disc case in Australia. Dr. Steven Yang completed the ... pain as a result of a degenerative lumbar disc at level L5-S1. The ...
Breaking Biology Technology:
(Date:3/30/2017)... The research team of The Hong Kong Polytechnic University (PolyU) ... ground breaking 3D fingerprint minutiae recovery and matching technology, pushing contactless ... use in identification, crime investigation, immigration control, security of access and ... ... A research team led by Dr Ajay Kumar ...
(Date:3/28/2017)... , March 28, 2017 The ... Hardware (Camera, Monitors, Servers, Storage Devices), Software (Video Analytics, ... Region - Global Forecast to 2022", published by MarketsandMarkets, ... 2016 and is projected to reach USD 75.64 Billion ... and 2022. The base year considered for the study ...
(Date:3/24/2017)... Research and Markets has announced the addition of the ... Forecast to 2025" report to their offering. ... The Global Biometric Vehicle Access System ... over the next decade to reach approximately $1,580 million by 2025. ... forecasts for all the given segments on global as well as ...
Breaking Biology News(10 mins):